Insider · CIK 0001785987
Yi Larson
Files at OLMA (Olema Pharmaceuticals, Inc.), RYZB (RayzeBio, Inc.). First filing -, latest -.
In brief
Yi Larson files SEC Form 4 as director at OLMA (Olema Pharmaceuticals, Inc.), and also at RYZB (RayzeBio, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Yi Larson has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 6 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 18, 2026 | OLMA Olema Pharmaceuticals, Inc. | AGrant or award Stock Option (right to buy)derivative | +29,500 | $0.00 | $0 | 29,500 | Jun 23, 2026 |
| Jun 11, 2025 | OLMA Olema Pharmaceuticals, Inc. | AGrant or award Stock Option (right to buy)derivative | +24,150 | $0.00 | $0 | 24,150 | Jun 13, 2025 |
| Jun 14, 2024 | OLMA Olema Pharmaceuticals, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +23,000 | $0.00 | $0 | 23,000 | Jun 18, 2024 |
| Feb 26, 2024 | RYZB RayzeBio, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -59,399 | - | - | 0 | Feb 27, 2024 |
| Feb 26, 2024 | RYZB RayzeBio, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -14,332 | - | - | 0 | Feb 27, 2024 |
| Feb 26, 2024 | RYZB RayzeBio, Inc. | DDisposition to issuer Employee Stock Option (right to buy)derivative | -40,848 | - | - | 0 | Feb 27, 2024 |
Questions about Yi Larson
Answered from the filings on this page, as of the latest one.
Is Yi Larson buying or selling?
Yi Larson has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Yi Larson's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Yi Larson has 0.
Where does Yi Larson file Form 4?
Yi Larson has filed Form 4 at OLMA (Olema Pharmaceuticals, Inc.); RYZB (RayzeBio, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.